Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 75%
filed 2026-06-04
Item 7.01
Hut 8 Corp.'s subsidiary Beacon Point DC LLC announced a $4.25 billion private offering of senior secured notes due 2042 under Rule 144A and Regulation S. While this is technically a debt issuance rather than equity, the scale ($4.25B) and the financing structure for a major capital project (352 MW data center in Texas) represent a material capital-raising event that would affect investor assessment of the company's leverage, financial structure, and growth strategy. The disclosure of a major debt offering of this magnitude is material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Aclaris Therapeutics' 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for three proposals: election of two directors (Anand Mehra, M.D. and Maxine Gowen, Ph.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstained, and Broker Non-Votes) are characteristic of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
Quoin Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare (MHLW) granted Orphan Drug Designation to QRX003 lotion for the treatment of Netherton Syndrome. This designation provides significant development incentives including prioritized consultation, reduced fees, tax benefits, priority review, and up to 10 years of market exclusivity, representing a material regulatory milestone for the company's pipeline.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Kavita Mahtani, a Class I director and member of the Audit Committee and Strategy & Financing Committee, notified the Company of her resignation from the Board effective June 11, 2026. The disclosure centers on her departure from the Board, which is a material executive departure given her committee memberships and tenure since April 2022.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Mark J. Hall, a director on Monster Beverage's Board, provided notice of his intention to resign as a director effective August 1, 2026, and as an employee of the Company's subsidiary effective April 1, 2027. The filing centers on the departure of a named executive and director, with no appointment of a replacement disclosed. The resignation is material as it reduces Board size and affects the composition of the Company's governance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-04
Item 1.01
Janus Living closed a registered underwritten public offering of 25 million shares of Class A-1 common stock on June 4, 2026, with an additional 3.75 million share option granted to underwriters. This is a material equity issuance that dilutes existing shareholders and raises capital through a registered public offering, fitting the dilutive_issuance category. The scale and public nature of the offering make it material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-04
Item 2.02
This is a straightforward earnings release disclosure under Item 2.02. Argan issued a press release on June 4, 2026 announcing financial results for the three months ended April 30, 2026, with the press release attached as Exhibit 99.1. Quarterly earnings releases are material to investors and are the canonical example of earnings_release events.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-06-04
Item 2.01
Dillard's completed a merger on June 4, 2026, whereby W.D. Company, Inc., a family holding company, merged into Dillard's with Dillard's surviving. The transaction involved the cancellation of WDC shares and distribution of Dillard's Common Stock and cash to WDC shareholders, representing a material change in capital structure and shareholder composition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-04
Item 8.01
The Company issued 3,283,844 shares of Class A common stock on June 4, 2026, in satisfaction of obligations under the Business Combination Agreement dated May 6, 2021. The disclosure notes that 6,561,282 shares have been issued cumulatively under the agreement, with contingent rights for up to 10,000,000 additional shares if stock price targets are met before October 19, 2026. This represents a material dilutive issuance tied to earn-out or contingent consideration obligations from the prior business combination.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MFA Financial's 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting tallies for three proposals: election of two Class I directors (Laurie S. Goodman and Richard C. Wald), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with clear majorities. Shareholder vote results are material to investors as they confirm governance outcomes and director/auditor continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Cindy Tang, the Company's CFO, resigned effective May 29, 2026. The resignation was formalized through a Separation Agreement disclosed under Item 1.01, and the CEO is temporarily assuming CFO duties pending a search for a replacement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-04
Item 8.01
The filing discloses a material acquisition of TopBuild by QXO, with the joint press release announcing a deadline for TopBuild stockholders to elect their form of consideration. The disclosure references the effective S-4 registration statement (File No. 333-295973) and joint proxy statement/prospectus filed in connection with the proposed acquisition, which are hallmarks of a material M&A transaction requiring stockholder approval.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-04
Item 2.02
The Company disclosed results of operations and financial condition for the three months ended March 31, 2026, presented via supplemental information furnished as an exhibit.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 95%
filed 2026-06-04
Item 7.01
On October 30, 2025, the Company and its debtor affiliates commenced voluntary Chapter 11 bankruptcy cases in the United States Bankruptcy Court for the Southern District of Texas (Case No. 25-90530). The Company is operating as a debtor-in-possession and has filed Monthly Operating Reports with the Bankruptcy Court.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from PennyMac's June 3, 2026 Annual Meeting of Stockholders. The filing presents voting outcomes for three proposals: election of ten directors, ratification of Deloitte & Touche LLP as independent auditor, and non-binding approval of executive compensation. All three proposals passed with substantial majorities, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are characteristic of Item 5.07 shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
W&T Offshore held its Annual Meeting of Shareholders and disclosed voting results on six proposals: election of six directors, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditors, and approval of an amendment to the 2023 Incentive Compensation Plan increasing authorized shares from 10,000,000 to 22,000,000.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-04
Item 8.01
The filing discloses a material acquisition of TopBuild by QXO, Inc., with the disclosure focused on the stockholder election deadline (June 29, 2026) for choosing the form of consideration. The joint press release announces a key procedural milestone in an ongoing acquisition transaction. This is a material M&A event under Item 8.01 (Other Events), as the acquisition itself was previously disclosed and this Item updates stockholders on a critical deadline in the transaction process.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 disclosure presents the complete results of Antero Midstream's June 3, 2026 annual stockholder meeting, including voting tallies for director elections (Peter A. Dea, W. Howard Keenan Jr., Janine J. McArdle), ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and frequency of future advisory compensation votes. The detailed vote counts and outcomes are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 50%
filed 2026-06-04
Item 1.01
B&G Foods entered into a material definitive agreement and announced a $475 million private placement of senior notes to refinance existing debt, representing a material capital restructuring transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a clear disclosure of shareholder vote results from Antero Resources' June 3, 2026 annual meeting, covering three proposals: election of Class I directors (Brenda R. Schroer and Thomas B. Tyree, Jr.), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 88%
filed 2026-06-04
Item 1.01
Datavault AI Inc. entered into a term sheet for a $2.0 billion structured financing transaction involving issuance of company shares at $1.55–$2.00 per share in exchange for preferred units, with potential dilution exceeding 50% of outstanding voting capital stock and counterparty board nomination rights upon each tranche closing. The transaction includes a $25 million binding fee obligation and four-tranche structure, representing a material capital-raising and potential change-of-control event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 7.01
ArcBest is providing a detailed operational update on Q2 2026 performance through May, including year-over-year and sequential trends for both Asset-Based and Asset-Light segments, along with forward-looking guidance on operating income and operating ratio improvements. While this is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a formal earnings release, the granular operational metrics, revenue trends, and specific Q2 guidance (e.g., Asset-Light operating income of $3–5 million) constitute material business information that would affect a reasonable investor's assessment of near-term performance and trends. The disclosure does not fit neatly into earnings_release (no full financial statements or formal press release format) but is clearly material forward-looking guidance on operational performance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This Item 5.07 filing discloses the final voting results from Scholar Rock's June 4, 2026 annual meeting of stockholders, covering three proposals: election of Class II directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Pulmonx's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting outcomes for three proposals: election of three Class III directors (Thomas W. Burns, Georgia Garinois-Melenikiotou, and Dana G. Mead, Jr.), ratification of BDO USA, P.C. as independent auditor, and a non-binding advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and audit oversight decisions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-04
Item 1.01
This disclosure describes an underwriting agreement for a secondary offering of 5,000,000 shares (plus up to 750,000 additional shares) by Apollo-affiliated selling stockholders, with the Company also agreeing to repurchase 750,000 shares. While technically a secondary offering (not a primary issuance by the Company), the Company's participation in the share repurchase and the overall dilutive impact on existing shareholders' ownership makes this a material capital structure event. The magnitude (5.75 million shares) and the involvement of a major shareholder (Apollo) constitute material disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 7.01
Femasys announced a 1-for-20 reverse stock split effective June 5, 2026, with trading on a split-adjusted basis beginning June 8, 2026. While reverse stock splits are material corporate actions affecting share structure and investor holdings, this disclosure does not fit neatly into the specific event-type taxonomy (not an earnings release, executive change, M&A, impairment, covenant breach, or other enumerated categories). The reverse split is a material event that would affect a reasonable investor's assessment of share ownership and market capitalization, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Southern Power Company entered into an underwriting agreement on June 1, 2026 to issue $600 million in senior notes due 2031. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories (it is not M&A activity, a dilutive equity issuance, or a covenant breach). The disclosure is appropriately classified as other_material given its significance and the absence of a more precise taxonomy match.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-04
Item 5.02
BeyondSpring appointed Min Qiu as Chief Executive Officer, Na Li as Chief Financial Officer, and Jiangwen Majeti as Vice Chair of the Board, all effective July 1, 2026, representing a significant change in the company's executive leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-04
Item 2.02
Item 2.02 disclosure of a press release issued on June 4, 2026, attached as Exhibit 99.1. This is the standard format for earnings releases under Item 2.02 of Form 8-K. The filing explicitly references a press release regarding results of operations and financial condition, which is the hallmark of an earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-04
Item 2.02
Item 2.02 disclosure of a press release issued on June 4, 2026 regarding Results of Operations and Financial Condition is a standard earnings release disclosure. The filing explicitly references a press release attached as Exhibit 99.1, which is the typical mechanism for disclosing quarterly or annual financial results to the market.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-04
Item 1.01
CONMED entered into purchase agreements to repurchase approximately $645.2 million aggregate principal amount of its 2.25% Convertible Senior Notes due 2027 for $637.2 million in cash. This is a material capital allocation and debt reduction activity that affects the company's financial structure and liquidity position, warranting disclosure under Item 1.01 as a material definitive agreement with significant financial consequences.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-04
Item 5.02
The Board adjusted the compensation of Todd W. Seyfert, President and CEO, including base salary ($800,000), annual target cash bonus (100% of Base Salary), performance-based equity awards (150% of Base Salary), and time-based equity awards (150% of Base Salary), along with supplemental restricted stock unit grants. This is a material compensatory arrangement adjustment for a named executive officer disclosed under Item 5.02(e).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of SolarEdge's annual meeting of stockholders held on June 3, 2026. The filing presents voting results for four proposals: election of seven directors, ratification of auditors (Kost Forer Gabbay & Kasierer), advisory approval of named executive officer compensation, and an amendment to the Certificate of Incorporation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content, making this unambiguously a shareholder vote results disclosure. The material nature is confirmed by the inclusion of director elections and executive compensation approval, both of which affect investor assessment of governance and management.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-04
Item 8.01
The company completed an IPO generating $150 million in gross proceeds from 15 million units, followed by a partial exercise of the over-allotment option on June 4, 2026 adding $7.5 million from 750,000 additional units, plus concurrent private placements totaling approximately $3.6 million. These unregistered or Section 4(a)(2)-exempt equity issuances are highly dilutive to existing shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-04
Item 2.02
X-Energy disclosed financial results for Q1 2026 (three months ended March 31, 2026) via a press release and earnings presentation furnished as exhibits under Item 2.02.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 7.01
X-Energy announced an early lock-up release date of September 1, 2026 for officers, directors, and substantial shareholders following the company's IPO, triggered by a blackout-period exception that signals when insider selling restrictions will lift.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-06-04
Item 8.01
TETRA Technologies announced and entered into an underwritten public offering of 10.8 million shares at $9.25 per share, with underwriters exercising a 30-day option to purchase an additional 1.6 million shares, expected to generate approximately $94.0 million in net proceeds plus $15.0 million from the option exercise.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-04
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Loar Holdings' June 2, 2026 Annual Meeting of Shareholders. The filing reports voting outcomes on four proposals: election of three directors (Raja Bobbili, Alison Bomberg, and Margaret McGetrick), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and frequency of future advisory votes on compensation. All proposals passed with substantial majorities. This is material as it documents the formal governance actions taken at the annual meeting.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-04
Item 8.01
The filing discloses a material acquisition transaction: Leggett & Platt entered into a Merger Agreement with Somnigroup International Inc. on April 13, 2026, whereby Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent. The Item 8.01 disclosure announces that the 30-day HSR Act waiting period expired on June 3, 2026, and the transaction is expected to close by year-end 2026, subject to specified conditions including shareholder approval and regulatory clearances. This is a change of control transaction material to any reasonable investor.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-04
Item 2.02
The filing discloses a press release announcing quarterly financial results for the fiscal 2026 quarter ended March 31, 2026, furnished as Exhibit 99.1 under Item 2.02. This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Fractyl Health announced positive one-year clinical trial results from the REVEAL-1 Cohort for its Revita procedure in obesity treatment, demonstrating 78% maintenance of GLP-1-induced weight loss with a favorable safety profile.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-04
Item 1.01
Syndax Pharmaceuticals entered into subscription agreements to issue $250 million of convertible senior notes due 2031 with conversion mechanics creating significant dilution potential to common shareholders. The unregistered private placement under Section 4(a)(2) will result in issuance of up to 13.6 million shares of common stock upon conversion, with net proceeds of approximately $243 million representing a material capital raise for the company.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-04
Item 2.03
Item 2.03 discloses creation of a direct financial obligation and incorporates Item 1.01 by reference, indicating a significant transaction creating material financial obligations consistent with M&A activity or similar material transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Goodyear entered into an underwriting agreement on June 1, 2026 to issue $1.05 billion in 8.875% Senior Notes due 2032, with the offering expected to close on June 4, 2026. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the more specific event categories (it is neither a dilutive equity issuance under Item 3.02, nor an M&A activity, nor a covenant breach). The disclosure is a straightforward debt offering registered under the Securities Act, disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 85%
filed 2026-06-04
Item 8.01
The filing discloses a previously undisclosed event of default on SBA debentures that has now been cured by submission of two candidates for background check approval. This represents resolution of a covenant breach or technical default—a material triggering event affecting the registrant's direct financial obligations. The disclosure of the prior default and its cure status is material to investors assessing credit risk and financial stability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-04
Item 1.01
Warner Bros. Discovery entered into $13B USD and €1.717B EUR term loan facilities on June 4, 2026, to refinance a $15B bridge loan. The refinancing is directly tied to the previously disclosed proposed acquisition of the Company by Paramount Skydance Corporation and is material to investors assessing the company's financial position and deal structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
Slide Insurance announced completion of its 2026-2027 catastrophe reinsurance program with material improvements: total capacity increased 65% to $5.463 billion, first-event coverage expanded by $1.424 billion, and 12 new reinsurance markets added. While this is a significant operational and financial event affecting the company's risk management posture and financial resilience, it does not fit neatly into the standard 8-K taxonomy (not M&A, not an impairment, not a covenant breach, not an earnings release). The disclosure is material to investors assessing the company's ability to manage catastrophic losses and support policyholders through hurricane season.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt commitments. This does not fit cleanly into covenant_breach (no violation alleged) or the other specific event types, as it is a routine debt issuance disclosure required by Item 2.03 rather than a triggering financial event like a covenant breach or material impairment.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-04
Item 3.02
Warburg Pincus Access Fund sold unregistered limited partnership units totaling $10,058,308 to third-party investors on May 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions. This private placement represents a material capital raise affecting the Fund's capitalization and investor dilution profile.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 8.01
This disclosure reports the Fund's NAV per share ($24.822) as of April 30, 2026, along with aggregate NAV ($569.2 million), portfolio fair value ($1,047.8 million), and debt-to-equity ratio (0.94x). While NAV reporting is routine for closed-end funds and investment companies, the specific financial metrics disclosed—particularly the debt-to-equity ratio and portfolio composition—would be material to investors assessing the Fund's leverage and financial position. However, this does not fit neatly into the more specific event categories (not earnings, not a restatement, not a covenant breach, not going-concern language), so it is classified as other_material.
View raw filing on EDGAR →